Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.81 USD
Change Today -0.01 / -1.22%
Volume 86.4K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 5:19 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$0.83
Previous Close
$0.82
Day High
$0.83
Day Low
$0.78
52 Week High
09/11/14 - $1.82
52 Week Low
05/29/15 - $0.64
Market Cap
60.3M
Average Volume 10 Days
138.4K
EPS TTM
$-0.34
Shares Outstanding
74.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States and internationally. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. Implant Sciences offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The company markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. Implant Sciences Corporation was founded in 1984 and is headquartered in Wilmington, Massachusetts.

74 Employees
Last Reported Date: 09/29/14
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $270.0K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $230.0K
Vice President of Technology & Product Develo...
Total Annual Compensation: $200.0K
Vice President, Sales, Marketing and Technica...
Total Annual Compensation: $245.0K
Compensation as of Fiscal Year 2014.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corporation Wins Tender for QS-B220 Desktop Explosives Trace Detectors from Three Major Parisian Airports

Implant Sciences Corporation announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports. Over the past few months, Implant Sciences has won a series of tenders in France, as well as throughout the EU. Following its two recent airport tender wins in France, the company's ETDs have been selected for deployment in over 95% of the French airports that serve more than 500,000 passengers annually. The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Implant Sciences Corp. Approves Amendment to Articles

Implant Sciences Corp. announced that at the annual general meeting held on July 1, 2015, shareholders of the company approved the amendment to the company's restated articles of organization to increase the number of authorized shares of common stock by 50,000,000 shares to 250,000,000 shares.

Implant Sciences Nabs More European Orders

Implant Sciences has announced new orders with airports in Finland, Belgium and Cyprus. The company announced that Finish airports have purchased 58 QS-B220 desktop explosives trace detectors that will be deployed during the next few months. Implant has also received an order from a second airport in Belgium to provide 13 of its QS-B220 desktop explosives trace detectors (ETD). Implant says the order was a competitive win. In the past two months Implant has sold more than 500 ETDs to customers in six countries in Europe. The company sold eight of the QS-B220 detectors to Paphos and Larnaca International Airports in Cyprus, which will be subject to upcoming European Union ETD regulations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.81 USD -0.01

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bruker Corp $21.05 USD +0.36
CR Bard Inc $196.65 USD +3.55
Safran SA €68.86 EUR +1.35
Thermo Fisher Scientific Inc $139.53 USD +0.41
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.